CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Unity Biotechnology›
Fundraising
Unity Biotechnology logo

Unity Biotechnology

UNITY Biotechnology, a US firm since 2011, develops treatments for osteoarthritis, eye, and lung diseases.

South San Francisco, CA, US🇺🇸
Founded
2009
Loading
Overview
Compare
Fundraising
Employees
Library

Unity Biotechnology - Funding History

Round

Date

Amount Raised

Raised To-Date

Investors

Post IPO
November 2023
$4,300,000
-
0
Post IPO
August 2020
$80,000,000
-
1
Series C
March 2018
$55,000,000
-
13
IPO
January 2018
-
-
0
Series B
August 2017
$35,000,000
$155,591,000
15
Series B
October 2016
$116,000,000
$120,591,000
7
Series A
January 2015
$2,300,000
$4,591,000
4
Series Unknown
July 2013
$2,041,000
$2,291,000
0
Convertible Note
May 2009
$250,000
$250,000
0

Unity Biotechnology - Investors

Unity Biotechnology has raised money from at least 22 different investors as of October 17, 2026

Name

Location

Links

Type

Employees

Round(s)

Hercules CapitalHercules Capital
Palo Alto, CA, US
LinkedIn
Investment Firm
178
Post IPO
FISFIS
Jacksonville, FL, US
LinkedIn
Company
69,000
Series BSeries C
The Longevity FundThe Longevity Fund
San Francisco, CA, US
LinkedIn
Investment Firm
2
Series C
Baillie Gifford & CoBaillie Gifford & Co
Edinburgh, City of Edinburgh, GB
LinkedIn
Investment Firm
1,860
Series BSeries C
InvusInvus
New York City, NY, US
LinkedIn
Investment Firm
75
Series BSeries C
VenrockVenrock
Palo Alto, CA, US
LinkedIn
Investment Firm
179
Series ASeries B
EcoR1 CapitalEcoR1 Capital
San Francisco, CA, US
LinkedIn
Investment Firm
19
Series C
Arch Venture PartnersArch Venture Partners
Chicago, IL, US
LinkedIn
Investment Firm
67
Series ASeries B
Altitude Life Science VenturesAltitude Life Science Ventures
Kirkland, WA, US
Investment Firm
7
Series C
Founders FundFounders Fund
San Francisco, CA, US
LinkedIn
Investment Firm
50
Series BSeries C